Position in UTHR
as of Mar 31, 2026
· filed Jun 3, 2026
Position Value
$626,186
+$125,781 QoQ
Shares Held
1,056
+2.8% QoQ
Ownership
0.002%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in UTHR Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Mar 31, 2026Parallel Advisors, LLC holds $7,470,447 across 34 Drug Manufacturers - Specialty & Generic names. UTHR ranks #3 (8.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ZTS |
Zoetis Inc.
|
27,846 | $3,291,675 | |
| 2 | RDY |
Dr Reddys Laboratories Ltd
|
88,173 | $1,221,196 | |
| 3 | UTHR |
UNITED THERAPEUTICS Corp
This page
|
1,056 | $626,186 | |
| 4 | TAK |
Takeda Pharmaceutical Co Ltd
|
24,651 | $456,536 | |
| 5 | VTRS |
Viatris Inc
|
26,426 | $357,015 | |
| 6 | HLN |
Haleon plc
|
30,272 | $303,022 | |
| 7 | ESPR |
Esperion Therapeutics, Inc.
|
96,254 | $263,735 | |
| 8 | NBIX |
Neurocrine Biosciences Inc
|
1,776 | $233,970 |
All Filings in UTHR
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $626,186 | 1,056 | Shares | Sole | 2026-06-03 | |
| 2025-12-31 | $500,405 | 1,027 | Shares | Sole | 2026-02-11 | |
| 2025-09-30 | $422,144 | 1,007 | Shares | Sole | 2025-11-13 | |
| 2025-06-30 | $340,222 | 1,184 | Shares | Sole | 2025-07-08 | |
| 2025-03-31 | $307,961 | 999 | Shares | Sole | 2025-04-08 | |
| 2024-12-31 | $384,595 | 1,090 | Shares | Sole | 2025-02-10 | |
| 2024-09-30 | $379,851 | 1,060 | Shares | Sole | 2024-11-13 | |
| 2024-06-30 | $298,481 | 937 | Shares | Sole | 2024-08-08 | |
| 2024-03-31 | $182,167 | 793 | Shares | Sole | 2024-05-06 | |
| 2023-12-31 | $160,519 | 730 | Shares | Sole | 2024-02-12 | |
| 2023-09-30 | $174,597 | 773 | Shares | Sole | 2024-05-20 | |
| 2023-06-30 | $157,174 | 712 | Shares | Sole | 2024-05-20 | |
| 2023-03-31 | $118,698 | 530 | Shares | Sole | 2024-05-20 | |
| 2022-12-31 | $133,483 | 480 | Shares | Sole | 2023-02-06 | |
| 2022-09-30 | $95,686 | 457 | Shares | Sole | 2022-11-10 | |
| 2022-06-30 | $109,101 | 463 | Shares | Sole | 2022-08-01 | |
| 2022-03-31 | $80,555 | 449 | Shares | Sole | 2022-04-28 | |
| 2021-12-31 | $135,914 | 629 | Shares | Sole | 2022-01-20 | |
| 2021-09-30 | $112,409 | 609 | Shares | Sole | 2021-11-02 | |
| 2021-06-30 | $105,313 | 587 | Shares | Sole | 2021-08-06 | |
| 2021-03-31 | $113,576 | 679 | Shares | Sole | 2021-04-23 | |
| 2020-12-31 | $89,556 | 590 | Shares | Sole | 2021-02-02 | |
| 2020-09-30 | $41,915 | 415 | Shares | Sole | 2020-10-27 | |
| 2020-06-30 | $78,166 | 646 | Shares | Sole | 2020-07-16 | |
| 2020-03-31 | $28,733 | 303 | Shares | Sole | 2020-04-27 | |
| No filing history on record for this holder in this stock. | ||||||